Cambridge-based Moderna already got $400M for a COVID vaccine that isn't available
(CNN) --- Moderna, one of the companies working on a treatment for Covid-19, said Wednesday that it's on track to finish enrollment for a phase 3 study of its vaccine by the end of…
